Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PLASMALG (B) 45-70 MG/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PLASMALG (B) 45-70 MG/ML SOLUCION PARA PERFUSION

Approved

STANDARD

PLASMALG (B) 45-70 MG/ML SOLUCION PARA PERFUSION

Octapharma S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 20, 2023
Approval ID: b72e7cd5c8277bd0
Company: Octapharma S.A.
Type: Standard

Approval Details

Approval Id: b72e7cd5c8277bd0
Drug Cima Aemps Name: PLASMALG (B) 45-70 MG/ML SOLUCION PARA PERFUSION
Register Number: 88675
Holder Company Name: Octapharma S.A.
Marketing Company Name: Octapharma S.A.
Authorization Date: 2023-02-20
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 45-70 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Octapharma S.A.

Active Ingredients

PROTEINA PLASMATICA HUMANA

9-14 g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 20, 2023

Approval ID

b72e7cd5c8277bd0

Type

Standard

Back to CIMA-AEMPS Approvals